Literature DB >> 12975750

Advances against aspergillosis.

William J Steinbach1, David A Stevens, David W Denning, Richard B Moss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12975750     DOI： 10.1086/376522

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.

Authors:  Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Nazhat Wasei; Willem J G Melchers; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

3.  Immunoproteome of Aspergillus fumigatus using sera of patients with invasive aspergillosis.

Authors:  Emylli D Virginio; Paula H Kubitschek-Barreira; Marjorie Vieira Batista; Marcelo R Schirmer; Eliana Abdelhay; Maria A Shikanai-Yasuda; Leila M Lopes-Bezerra
Journal:  Int J Mol Sci       Date:  2014-08-20       Impact factor: 5.923

Review 4.  GM-CSF: Orchestrating the Pulmonary Response to Infection.

Authors:  Thomas S McCormick; Rana B Hejal; Luis O Leal; Mahmoud A Ghannoum
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.